Evidence map›Paper›PMID 39625540›Full record

ReviewCellular and molecular neurobiology2024

The Role of Extracellular Vesicles and Microparticles in Central Nervous System Disorders: Mechanisms, Biomarkers, and Therapeutic Potential.

Soroush Najdaghi, Delaram Narimani Davani, Hamed Fouladseresht, Narges Ebrahimi, Mark J M Sullman, Marjan Moradi, Nahid Eskandari

Abstract readReview
In one paragraph

Review in Cellular and molecular neurobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Soroush NajdaghiNeuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Delaram Narimani DavaniNeuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Hamed FouladsereshtImmunology Department, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Narges EbrahimiNeuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mark J M SullmanDepartment of Social Sciences, School of Humanities and Social Sciences, University of Nicosia, Nicosia, Cyprus.
Marjan MoradiDepartement of Genetics, School of Science, Shahrekord University, Shahrakord, Iran.
Nahid EskandariImmunology Department, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran. neskandari@med.mui.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microscopic, membranous vesicles known as extracellular vesicles (EVs) have been proposed to play a role in the mechanisms underlying central nervous system (CNS) diseases. EVs are secreted by a variety of cells, including myeloid, endothelial, microglial, oligodendroglial, and mesenchymal stem cells (MSCs). Body fluids such as plasma, urine, and cerebrospinal fluid (CSF) contain microparticles (MPs). The detection of MPs in CSF may indicate genetic or environmental susceptibility to conditions such as schizophrenia, schizoaffective disorder, and bipolar disorder. MPs of different origins can exhibit changes in specific biomarkers at various stages of the disease, aiding in the diagnosis and monitoring of neurological conditions. However, understanding the role and clinical applications of MPs is complicated by challenges such as their isolation and dual roles within the CNS. In this review, we discuss the history, characteristics, and roles of MPs in CNS diseases. We also provide practical insights for future research and highlight the challenges that obscure the therapeutic potential of MPs.

Indexed as

BiomarkersCell-Derived MicroparticlesCentral Nervous System DiseasesExtracellular VesiclesAnimalsHumansBiomarkersAlzheimer’s diseaseCentral nervous systemExtracellular vesiclesMicroparticlesNeuroimmunologyParkinson's disease

Identifiers

PMID39625540
PMCPMC11614997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.